Management of Clostridioides difficile Treatment Failure

Definition and Treatment Algorithm

For patients experiencing C. difficile treatment failure, the recommended next step is to switch to oral vancomycin 125 mg four times daily for 10 days, or if already on vancomycin, consider fidaxomicin 200 mg twice daily for 10 days, as recommended by the Journal of Crohn's and Colitis 1, 2
Treatment failure should be considered if there is no clinical response after 3 days of appropriate therapy, according to Praxis Medical Insights 2
Ongoing diarrhea under CDI treatment may guide management decisions, though there is risk of false-positive results if repeat testing is performed, as noted in the Journal of Crohn's and Colitis 1
Clinical assessment rather than repeat testing should generally be used to determine response, as recommended by the Journal of Crohn's and Colitis 1

If initial treatment was metronidazole, switch to oral vancomycin 125 mg four times daily for 10 days, as recommended by the Journal of Crohn's and Colitis and Praxis Medical Insights 1, 2
If initial treatment was vancomycin, consider fidaxomicin 200 mg twice daily for 10 days, or an alternative approach with vancomycin in a tapered and pulsed regimen, as recommended by the Journal of Crohn's and Colitis and Clinical Microbiology and Infection 1, 4, 5
For severe CDI treatment failure, oral vancomycin 500 mg four times daily should be considered, along with adding intravenous metronidazole 500 mg every 8 hours if necessary, as recommended by the Journal of Crohn's and Colitis and World Journal of Emergency Surgery 1, 3, 4

Fecal microbiota transplantation (FMT) should be considered after failure of appropriate antibiotic treatments, particularly for multiple recurrences, with success rates ranging from 70% to 90%, as noted in Gut and the Journal of Crohn's and Colitis 1, 6
Bezlotoxumab, a monoclonal antibody against C. difficile toxin B, may be considered to reduce recurrence rates in high-risk patients, as recommended by the Journal of Crohn's and Colitis 1
Discontinue the inciting antibiotic as soon as possible, and avoid antiperistaltic agents and opiates which can mask symptoms and potentially worsen disease, as recommended by Praxis Medical Insights 2, 4

Ensure proper diagnosis of CDI treatment failure versus new-onset IBD flare, as symptoms may overlap, as noted in the Journal of Crohn's and Colitis 1
Hand hygiene with soap and water is required, as alcohol-based hand sanitizers are ineffective against C. difficile spores, as recommended by Praxis Medical Insights 4
Using metronidazole for severe CDI or for recurrent episodes has higher failure rates, and continuing unnecessary antibiotics that may perpetuate gut dysbiosis should be avoided, as recommended by the Journal of Crohn's and Colitis and Praxis Medical Insights 1, 2, 4